Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-Global

Publisher Name :
Date: 01-Nov-2016
No. of pages: 128
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023" Report provides an overview of the disease and market size of the CMV for theglobal, United States, EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan for 2013-2023. It also includes global historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMVfrom 2013-2023. According to DelveInsight, the Global Diagnosed cases for Cytomegalovirus (CMV) Infection are expected to increase at a CAGR of 0.047% to 172,864 cases in 2023. Cytomegalovirus (CMV) infection is caused by Cytomegalovirus (CMV), a member of the herpes virus family. Upon initial infection, CMV infects the epithelial cells of the salivary gland, resulting in a persistent infection and viral shedding. Person can be infected with CMV at any point of time in life and is not easily diagnosed as no symptoms are shown.

As per DelveInsight's estimation, the global market size of Cytomegalovirus (CMV) infection shall reach to USD 1,210.4 Million by the end of 2023. The market size for Prophylaxis is expected to grow at a CAGR 6.57% from 2013-2023, while the sales for the therapeutic shall increase at a CAGR of 3.44% from the 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs.

- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.

- It also provides Market size of Cytomegalovirus (CMV) infection for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.

Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-Global

Table of Contents

Cytomegalovirus Infections
Disease Overview
Symptoms of cytomegalovirus (CMV) Infection
Etiology
Risk Factors
Pathogenesis of human cytomegalovirus
Pathophysiology of cytomegalovirus infection
Diagnosis
Treatment Algorithm for Cytomegalovirus Infections
Treatment for Congenital CMV Infection
Treatment of Ganciclovir resistant CMV
Treatment Guidelines
Recommendations for Treating Cytomegalovirus Infections
Disease Management
Epidemiology and Patient Population
Global
Global CMV Prevalent, Diagnosed and Treatable Cases
United States
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infants Patients at High Risk of CMV
HIV Patients at High Risk of CMV
Europe
Italy
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infants Patients at High Risk of CMV
HIV Patients at High Risk of CMV
Spain
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infants Patients at High Risk of CMV
HIV Patients at High Risk of CMV
United Kingdom
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infants Patients at High Risk of CMV
HIV Patients at High Risk of CMV
Germany
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infants Patients at High Risk of CMV
HIV Patients at High Risk of CMV
France
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infants Patients at High Risk of CMV
HIV Patients at High Risk of CMV
Japan
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infant Patients at High Risk of CMV
HIV Patients at High Risk of CMV in Japan
Unmet Medical Needs
Marketed Products
Valcyte (Valganciclovir hydrochloride)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
FOSCAVIR (foscarnet sodium)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
CytoGam (Cytomegalovirus Immune Globulin Intravenous-Human)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
CytoTect CP
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
Valtrex (Valacyclovir hydrochloride)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
Emerging Products Analysis
Emerging Therapies
1. Approved Products
Cytovir CMV: Cell Medica Ltd.
Product Description
Research and Development
Product Development Activities
2. Pipeline Products (Phase III)
CytoTect CP 70: Biotest AG.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Letermovir: Merck & Co.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Brincidofovir: Chimerix Inc.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
ASP0113: Astellas Pharma Global Development, Inc.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Human Cytomegalovirus Immune Globulin: CSL Behring
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Global Market Size
United States
Europe
Italy
Germany
France
Spain
United Kingdom
Japan
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Total CMV Prevalent, Diagnosed and Treatable Cases (2013-2023)
Table 2: Total CMV Prevalent, Diagnosed and Treatable Cases for United States (2013-2023)
Table 3: CMV Patients among Transplants in United States (2013-2023)
Table 4: Infants Patients at High Risk of CMV in United States (2013-2023)
Table 5: HIV Patients at High Risk of CMV in United States (2013-2023)
Table 6 Total CMV Prevalent, Diagnosed and Treatable Cases for Italy (2013-2023)
Table 7: CMV Patients among Transplants in Italy (2013-2023)
Table 8: Infants Patients at High Risk of CMV in Italy (2013-2023)
Table 9: HIV Patients at High Risk of CMV in Italy (2013-2023)
Table 10: Total CMV Prevalent, Diagnosed and Treatable Cases for Spain (2013-2023)
Table 11: CMV Patients among Transplants in Spain (2013-2023)
Table 12: Infants Patients at High Risk of CMV in Spain (2013-2023)
Table 13: HIV Patients at High Risk of CMV in Spain (2013-2023)
Table 14: Total CMV Prevalent, Diagnosed and Treatable Cases for United Kingdom (2013-2023)
Table 15: CMV Patients among Transplants in United Kingdom (2013-2023)
Table 16: Infants Patients at High Risk of CMV in United Kingdom (2013-2023)
Table 17: HIV Patients at High Risk of CMV in United Kingdom (2013-2023)
Table 18: Total CMV Prevalent, Diagnosed and Treatable Cases for Germany (2013-2023)
Table 19: CMV Patients among Transplants in Germany (2013-2023)
Table 20: Infants Patients at High Risk of CMV in Germany (2013-2023)
Table 21: HIV Patients at High Risk of CMV in Germany (2013-2023)
Table 22: Total CMV Prevalent, Diagnosed and Treatable Cases for France (2013-2023)
Table 23: CMV Patients among Transplants in France (2013-2023)
Table 24: Infants Patients at High Risk of CMV in France (2013-2023)
Table 25: HIV Patients at High Risk of CMV in France (2013-2023)
Table 26: Total CMV Prevalent, Diagnosed and Treatable Cases for Japan (2013-2023)
Table 27: CMV Patients among Transplants in Japan (2013-2023)
Table 28: Infants Patients at High Risk of CMV in Japan (2013-2023)
Table 29: HIV Patients at High Risk of CMV in Japan (2013-2023)
Table 30:Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)
Table 31:Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)
Table 32:Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)
Table 33: Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)
Table 34: Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)
Table 35: Total Market size of Cytomegalovirus (CMV) Infection USD, Million (2013-2023)
Table 36: Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)
Table 37:Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)

List of Figures

Figure 1: Risk Factors CMV infection, 2016
Figure 2: Total CMV Prevalent, Diagnosed and Treatable Cases (2013-2023)
Figure 3: Total CMV Prevalent, Diagnosed and Treatable Cases for United States (2013-2023)
Figure 4: CMV Patients among Transplants in United States (2013-2023)
Figure 5: Infants Patients at High Risk of CMV in United States (2013-2023)
Figure 6: HIV Patients at High Risk of CMV in United States (2013-2023)
Figure 7: Total CMV Prevalent, Diagnosed and Treatable Cases for Italy (2013-2023)
Figure 8: CMV Patients among Transplants in Italy (2013-2023)
Figure 9: Infants Patients at High Risk of CMV in Italy (2013-2023)
Figure 10: HIV Patients at High Risk of CMV in Italy (2013-2023)
Figure 11: Total CMV Prevalent, Diagnosed and Treatable Cases for Spain (2013-2023)
Figure 12: CMV Patients among Transplants in Spain (2013-2023)
Figure 13: Infants Patients at High Risk of CMV in Spain (2013-2023)
Figure 14: HIV Patients at High Risk of CMV in Spain (2013-2023)
Figure 15: Total CMV Prevalent, Diagnosed and Treatable Cases for United Kingdom (2013-2023)
Figure 16: CMV Patients among Transplants in United Kingdom (2013-2023)
Figure 17: Infants Patients at High Risk of CMV in United Kingdom (2013-2023)
Figure 18: HIV Patients at High Risk of CMV in United Kingdom (2013-2023)
Figure 19: Total CMV Prevalent, Diagnosed and Treatable Cases for Germany (2013-2023)
Figure 20: CMV Patients among Transplants in Germany (2013-2023)
Figure 21: Infants Patients at High Risk of CMV in Germany (2013-2023)
Figure 22: HIV Patients at High Risk of CMV in Germany (2013-2023)
Figure 23: Total CMV Prevalent, Diagnosed and Treatable Cases for France (2013-2023)
Figure 24:CMV Patients among Transplants in France (2013-2023)
Figure 25: Infants Patients at High Risk of CMV in France (2013-2023)
Figure 26: HIV Patients at High Risk of CMV in France (2013-2023)
Figure 27: Total CMV Prevalent, Diagnosed and Treatable Cases for Japan (2013-2023)
Figure 28: CMV Patients among Transplants in Japan (2013-2023)
Figure 29: Infants Patients at High Risk of CMV in Japan (2013-2023)
Figure 30: HIV Patients at High Risk of CMV in Japan(2013-2023)
Figure 31: Total Market Size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
Figure 32: US Market Size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
Figure 33: Italy market size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
Figure 34: Germany market size of Cytomegalovirus (CMV) Infection in USD, Million (2013-2023)
Figure 35: France market size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
Figure 36: Spain market size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
Figure 37: UK market size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
Figure 38: Japan market size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Impetigo - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 45
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Pipeline Review, H2 2016, provides an overview of the Impetigo (Infectious Disease) pipeline landscape.Impetigo is a highly contagious skin condition. Impetigo is caused by two bacteria streptococcus pyogenes and staphylococcus aureus. Symptoms include fluid-filled blisters, itchy rash, skin lesions and swollen lymph nodes. Risk factors include skin-to-skin contact, injury to the skin, having diabet......
  • Q Fever - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 41
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Q Fever - Pipeline Review, H2 2016, provides an overview of the Q Fever (Infectious Disease) pipeline landscape.Q fever, also called query fever, is a bacterial infection caused by the bacteria Coxiella burnetii. Common symptoms of Q fever include high fever, cough, headache, diarrhea, nausea, abdominal pain, jaundice and muscle pain. Risk factors include occupations. Treatment includes antibiotics.......
  • Global Niclosamide Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Niclosamide Revenue, means the sales value of Niclosamide This report studies Niclosamide in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Shanxi Hanjiang Pharmaceutical - Anhui Topsun Pharmaceutical - Zhengqing Pharmaceutical Group......
  • Global Meningococcal Infections Vaccine Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Meningococcal Infections Vaccine Revenue, means the sales value of Meningococcal Infections Vaccine This report studies Meningococcal Infections Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Sanofi-Pasteur - Beijing Tiantan Biologi......
  • United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Market Report 2016
    Published: 29-Nov-2016        Price: US 3800 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Revenue, means the sales value of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections This report studies sales (consumption) of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer - Merck - Astra......
  • Escherichia coli Infections - Pipeline Review, H2 2016
    Published: 23-Nov-2016        Price: US 2000 Onwards        Pages: 165
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Escherichia coli Infections - Pipeline Review, H2 2016, provides an overview of the Escherichia coli Infections (Infectious Disease) pipeline landscape.Escherichia coli (E. coli) bacteria normally live in the intestines of healthy people and animals. Escherichia coli infections are caused by coming into contact with the feces, or stool, of humans or animals or drink water or eat food that has been contaminated......
  • Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016
    Published: 23-Nov-2016        Price: US 2000 Onwards        Pages: 177
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016, provides an overview of the Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline landscape.Cytomegalovirus (CMV) is a contagious infection of the caused by the member of the herpes virus family. CMV is spread through saliva or urine. Symptoms include fever, pneumonia, weight loss, hearing, neurological and developmental problems. The pr......
  • Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2016
    Published: 23-Nov-2016        Price: US 2000 Onwards        Pages: 191
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2016, provides an overview of the Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline landscape.H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. Symptoms include fever and cough, acute respiratory distress, shortness......
  • Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2016
    Published: 23-Nov-2016        Price: US 2000 Onwards        Pages: 273
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2016, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline landscape.Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pai......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs